VKTX
NASDAQ
$36.38
Viking Therapeutics Inc (VKTX)
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on developing new therapies for metabolic and endocrine disorders. The company is headquartered in San Diego, California.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $92.58 (+154.48%)
Market Cap
$4.38B
EPS 5Y CAGR
+47.58%
FCF 5Y CAGR
+64.39%
Free Cash Flow Yield
-7.77%
Price Chart
Valuation
Market Cap$4.38B
P/B8.82
Profitability
EBITDA-$472M
EPS-$4.13
Financial Health
Free Cash Flow Yield-7.77%
Growth & Risk
EPS 5Y CAGR+47.58%
FCF 5Y CAGR+64.39%
Beta (5Y)1.52
Sharpe Ratio0.54